These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy. Basu PP; Shah NJ Clin Liver Dis; 2015 Aug; 19(3):461-72. PubMed ID: 26195201 [TBL] [Abstract][Full Text] [Related]
64. Alternations in Dynamic and Static Functional Connectivity Density in Chronic Smokers. Yang Z; Wen M; Wei Y; Huang H; Zheng R; Wang W; Gao X; Zhang M; Cheng J; Han S; Zhang Y Front Psychiatry; 2022; 13():843254. PubMed ID: 35530028 [TBL] [Abstract][Full Text] [Related]
65. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent. Gupta D; Ingle M; Shah K; Phadke A; Sawant P J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627 [TBL] [Abstract][Full Text] [Related]
66. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Bajaj JS; Hafeezullah M; Franco J; Varma RR; Hoffmann RG; Knox JF; Hischke D; Hammeke TA; Pinkerton SD; Saeian K Gastroenterology; 2008 Nov; 135(5):1591-1600.e1. PubMed ID: 18723018 [TBL] [Abstract][Full Text] [Related]
67. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy. Kircheis G; Hilger N; Häussinger D Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582 [TBL] [Abstract][Full Text] [Related]
69. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Romero-Gómez M; Grande L; Camacho I Hepatology; 2004 Apr; 39(4):939-43. PubMed ID: 15057897 [TBL] [Abstract][Full Text] [Related]
70. Olfactory deficits in patients affected by minimal hepatic encephalopathy: a pilot study. Zucco GM; Amodio P; Gatta A Chem Senses; 2006 Mar; 31(3):273-8. PubMed ID: 16436687 [TBL] [Abstract][Full Text] [Related]
71. Abnormal functional connectivity in patients with vascular cognitive impairment, no dementia: a resting-state functional magnetic resonance imaging study. Sun YW; Qin LD; Zhou Y; Xu Q; Qian LJ; Tao J; Xu JR Behav Brain Res; 2011 Oct; 223(2):388-94. PubMed ID: 21605598 [TBL] [Abstract][Full Text] [Related]
72. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460 [TBL] [Abstract][Full Text] [Related]
73. Hyper-connectivity of subcortical resting-state networks in social anxiety disorder. Arnold Anteraper S; Triantafyllou C; Sawyer AT; Hofmann SG; Gabrieli JD; Whitfield-Gabrieli S Brain Connect; 2014 Mar; 4(2):81-90. PubMed ID: 24279709 [TBL] [Abstract][Full Text] [Related]
74. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Sharma P; Sharma BC; Puri V; Sarin SK Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781 [TBL] [Abstract][Full Text] [Related]
75. Prolonged N200 is the early neurophysiologic change in the patient with minimal hepatic encephalopathy. Moon JH; Jun DW; Yum MK; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Seol IJ; Oh JW; Kim CR Scand J Gastroenterol; 2014 May; 49(5):604-10. PubMed ID: 24646220 [TBL] [Abstract][Full Text] [Related]
76. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance. Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770 [TBL] [Abstract][Full Text] [Related]
77. Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy. Lin WC; Hsu TW; Chen CL; Lu CH; Chen HL; Cheng YF PLoS One; 2015; 10(5):e0126834. PubMed ID: 25973853 [TBL] [Abstract][Full Text] [Related]
78. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Sharma P; Sharma BC; Sarin SK Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401 [TBL] [Abstract][Full Text] [Related]
79. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Kale RA; Gupta RK; Saraswat VA; Hasan KM; Trivedi R; Mishra AM; Ranjan P; Pandey CM; Narayana PA Hepatology; 2006 Apr; 43(4):698-706. PubMed ID: 16557540 [TBL] [Abstract][Full Text] [Related]
80. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Sharma P; Sharma BC; Puri V; Sarin SK Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]